Response to neoadjuvant immune checkpoint inhibitor (ICI)-based therapy in oncogene-driven resectable non-small cell lung cancer (NSCLC) Meeting Abstract

  

Authors:	Rosner, S.; Sivapalan, L.; Zahurak, M.; Thummalapalli, R.; Rayes, R.; Connor, S.; Sanber, K.; Reuss, J. E.; Pereira, G.; Smith, K. N.; Anagnostou, V.; Broderick, S.; Jones, D. R.; Brahmer, J. R.; Marrone, K. A.; Spicer, J.; Chaft, J. E.; Forde, P. M.
Abstract Title:	Response to neoadjuvant immune checkpoint inhibitor (ICI)-based therapy in oncogene-driven resectable non-small cell lung cancer (NSCLC)
Meeting Title:	2023 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	41
Issue:	16 Suppl.
Meeting Dates:	2023 Jun 2-6
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2023-06-01
Language:	English
DOI:	10.1200/JCO.2023.41.16_suppl.8523
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=164014962&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	Meeting abstract: 8523 -- Meeting also presented virtually -- NLM UID: 8309333. -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/209514